Your browser doesn't support javascript.
loading
Spanish cohort of VEXAS syndrome: clinical manifestations, outcome of treatments and novel evidences about UBA1 mosaicism.
Mascaro, Jose Manuel; Rodriguez-Pinto, Ignasi; Poza, Gabriela; Mensa-Vilaro, Anna; Fernandez-Martin, Julian; Caminal-Montero, Luis; Espinosa, Gerard; Hernández-Rodríguez, Jose; Diaz, Marina; Rita-Marques, Joana; Sanmarti, Raimon; Castañeda, Santos; Colunga, Dolores; Coto-Hernández, Rubén; Fanlo, Patricia; Elejalde, Jose Ignacio; Bujan, Segundo; Figueras, Ignasi; Marco, Francisco Manuel; Andrés, Mariano; Suárez, Silvia; Gonzalez-Garcia, Andres; Fustà-Novell, Xavier; Garcia-Belando, Clara; Granados, Ana; Fernandez-Figueras, Maria Teresa; Quilis, Neus; Orriols-Caba, Maria; Gómez de la Torre, Ricardo; Cid, Maria Cinta; Espígol-Frigolé, Georgina; Alvarez-Abella, Alba; Labrador, Eztizen; Rozman, Maria; Lopez-Guerra, Monica; Castillo, Paola; Alamo-Moreno, Jose R; Gonzalez-Roca, Eva; Plaza, Susana; Fabregat, Virginia; Lara, Rocio; Vicente-Rabaneda, Esther F; Tejedor-Vaquero, Sonia; Magri, Giuliana; Bonet, Nuria; Solis-Moruno, Manuel; Cerutti, Andrea; Fornas, Oscar; Casals, Ferran; Yagüe, Jordi.
Afiliação
  • Mascaro JM; Department of Dermatology, Hospital Clínic, Barcelona, Spain.
  • Rodriguez-Pinto I; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
  • Poza G; School of Medicine, Universitat de Barcelona, Barcelona, Spain.
  • Mensa-Vilaro A; Department of Internal Medicine, Hospital Mútua de Terrassa, Terrassa, Spain.
  • Fernandez-Martin J; Department of Internal Medicine, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain.
  • Caminal-Montero L; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
  • Espinosa G; Department of Immunology, Hospital Clínic, Barcelona, Spain.
  • Hernández-Rodríguez J; Department of Internal Medicine, Hospital Álvaro Cunqueiro, Vigo, Spain.
  • Diaz M; Department of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Rita-Marques J; Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.
  • Sanmarti R; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
  • Castañeda S; School of Medicine, Universitat de Barcelona, Barcelona, Spain.
  • Colunga D; Department of Autoimmune Diseases, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Coto-Hernández R; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
  • Fanlo P; School of Medicine, Universitat de Barcelona, Barcelona, Spain.
  • Elejalde JI; Department of Autoimmune Diseases, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Bujan S; Department of Haematology, Hospital Clínic, Barcelona, Spain.
  • Figueras I; Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Marco FM; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
  • Andrés M; School of Medicine, Universitat de Barcelona, Barcelona, Spain.
  • Suárez S; Department of Rheumatology, Hospital Clínic, Barcelona, Spain.
  • Gonzalez-Garcia A; Department of Rheumatology, Hospital Universitario La Princesa, Madrid, Spain.
  • Fustà-Novell X; Instituto de Investigaciones Sanitarias Princesa (IIS-Princesa), Madrid, Spain.
  • Garcia-Belando C; Cátedra UAM-Roche, EPID-Future, Department of Medicine, School of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
  • Granados A; Department of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Fernandez-Figueras MT; Department of Internal Medicine, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Quilis N; Instituto de Investigación Sanitaria del Principado de Asturias, Oviedo, Spain.
  • Orriols-Caba M; Department of Internal Medicine, Hospital Universitario de Navarra, Pamplona, Spain.
  • Gómez de la Torre R; Department of Internal Medicine, Hospital Universitario de Navarra, Pamplona, Spain.
  • Cid MC; Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Espígol-Frigolé G; Department of Dermatology, Hospital de Bellvitge, Barcelona, Spain.
  • Alvarez-Abella A; Department of Immunology, Hospital General Universitario de Alicante Dr Balmis, Alicante, Spain.
  • Labrador E; Alicante Institute for Health and Biomedical Research, Alicante, Spain.
  • Rozman M; Alicante Institute for Health and Biomedical Research, Alicante, Spain.
  • Lopez-Guerra M; Seccion de Reumatologia, Hospital General Universitario de Alicante, Alicante, Spain.
  • Castillo P; Department of Clinic Medicine, Universidad Miguel Hernandez de Elche, Elche, Spain.
  • Alamo-Moreno JR; Department of Internal Medicine, Hospital Valle del Nalón, Langreo, Spain.
  • Gonzalez-Roca E; Systemic Autoimmune Diseases Unit, Department of Internal Medicine, Hospital Universitario Ramón y Cajal | IRYCIS, Madrid, Spain.
  • Plaza S; Department of Dermatology, Althaia Foundation of Manresa, Manresa, Spain.
  • Fabregat V; Department of Rheumatology, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain.
  • Lara R; Department of Internal Medicine, Hospital Universitari Parc Taulí, Sabadell, Spain.
  • Vicente-Rabaneda EF; Department of Pathology, Hospital Universitari General de Catalunya San Cugat del Valles, Sant Cugat del Valles, Spain.
  • Tejedor-Vaquero S; Department of Rheumatology, Hospital Universitari de Vinalopo, Elche, Spain.
  • Magri G; Department of Internal Medicine, Hospital comarcal Alt Penedès, Consorci Sanitari Alt Penedès-Garraf, Vilafranca del Penedès, Spain.
  • Bonet N; Department of Autoimmune Diseases, Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Solis-Moruno M; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
  • Cerutti A; School of Medicine, Universitat de Barcelona, Barcelona, Spain.
  • Fornas O; Department of Autoimmune Diseases, Hospital Clinic de Barcelona, Barcelona, Spain.
  • Casals F; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
  • Yagüe J; School of Medicine, Universitat de Barcelona, Barcelona, Spain.
Ann Rheum Dis ; 82(12): 1594-1605, 2023 12.
Article em En | MEDLINE | ID: mdl-37666646
ABSTRACT

BACKGROUND:

The vacuoles, E1-enzyme, X linked, autoinflammatory and somatic (VEXAS) syndrome is an adult-onset autoinflammatory disease (AID) due to postzygotic UBA1 variants.

OBJECTIVES:

To investigate the presence of VEXAS syndrome among patients with adult-onset undiagnosed AID. Additional studies evaluated the mosaicism distribution and the circulating cytokines.

METHODS:

Gene analyses were performed by both Sanger and amplicon-based deep sequencing. Patients' data were collected from their medical charts. Cytokines were quantified by Luminex.

RESULTS:

Genetic analyses of enrolled patients (n=42) identified 30 patients carrying UBA1 pathogenic variants, with frequencies compatible for postzygotic variants. All patients were male individuals who presented with a late-onset disease (mean 67.5 years; median 67.0 years) characterised by cutaneous lesions (90%), fever (66.7%), pulmonary manifestations (66.7%) and arthritis (53.3%). Macrocytic anaemia and increased erythrocyte sedimentation rate and ferritin were the most relevant analytical abnormalities. Glucocorticoids ameliorated the inflammatory manifestations, but most patients became glucocorticoid-dependent. Positive responses were obtained when targeting the haematopoietic component of the disease with either decitabine or allogeneic haematopoietic stem cell transplantation. Additional analyses detected the UBA1 variants in both haematopoietic and non-haematopoietic tissues. Finally, analysis of circulating cytokines did not identify inflammatory mediators of the disease.

CONCLUSION:

Thirty patients with adult-onset AID were definitively diagnosed with VEXAS syndrome through genetic analyses. Despite minor interindividual differences, their main characteristics were in concordance with previous reports. We detected for the first time the UBA1 mosaicism in non-haematopoietic tissue, which questions the previous concept of myeloid-restricted mosaicism and may have conceptual consequences for the disease mechanisms.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite / Mosaicismo Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite / Mosaicismo Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Espanha